Myocardial contractility after infarction and carnitine palmitoyltransferase I inhibition in rats

By Gunther J.   Wagner K.-D.   Theres H.   Schimke I.   Born A.   Scholz H.   Vetter R.  

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite

Carnitine Palmitoyltransferase-I, a New Target for the Treatment of Heart Failure: Perspectives on a Shift in Myocardial Metabolism as a Therapeutic Intervention

By Sushma A. Mengi   Naranjan S. Dhalla  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 4, 2004-01 ,pp. : 201-209

Adis International

Access to resources Recommend Favorite

Comparison of (+)- and (-)-Hemipalmitoylcarnitinium as Inhibitors of Hepatic Mitochondrial Carnitine Palmitoyltransferases in Diabetic Rats

By  

Medicinal Chemistry, Vol. 1, Iss. 5, 2005-09 ,pp. : 445-453

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of mitochondrial carnitine palmitoyltransferase-1 by a trimetazidine derivative, S-15176

By Hamdan M.   Urien S.   Le Louet H.   Tillement J-P.   Morin D.  

Pharmacological Research, Vol. 44, Iss. 2, 2001-08 ,pp. : 99-104

Academic Press

Access to resources Recommend Favorite

The Effects of Drug Metabolizing Enzyme Inhibitors on Hepatic Efflux and Uptake Transporters

By  

Drug Metabolism Letters, Vol. 11, Iss. 2, 2018-02 ,pp. : 111-118

Bentham Science Publishers

Access to resources Recommend Favorite